BVS
Bioventus Inc.
NASDAQ · Healthcare · Medical - Devices · US
$13.49
+1.43%Forward multiples
Based on analyst estimates
- P/E forward
- 15.96x
- P/E 2026E
- 17.20x
- P/E 2027E
- 14.56x
- P/E 2028E
- 12.62x
- P/S forward
- 1.46x
Trailing multiples
Trailing twelve months
- P/E TTM
- 16.79x
- PEG TTM
- 3.19x
- Price / book
- 4.04x
- Price / sales
- 1.58x
- Price / cash flow
- 9.51x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- 2.07x
- EV / EBITDA
- 11.61x
- EV / EBIT
- 19.49x
- Market cap
- $921.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026